33 reports

  • F. Hoffmann-La Roche
  • Vendor overview

You can easily book an appointment with one online.

  • Nanoparticle
  • Pharmaceutical
  • World
  • Market Size
  • Hoffmann-La Roche Inc.
  • MARKET SHARE

Pharmaceuticals in Europe Summary Pharmaceuticals in Europe industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2013-17, and forecast to 2022). The profile also contains descriptions of the leading players including key financial...

  • Pharmaceutical
  • F. Hoffmann-La Roche Ltd.
  • Hoffmann-La Roche Inc.
  • Johnson & Johnson
  • Novartis AG
  • MARKET SHARE

Pharmaceuticals in Scandinavia Summary Pharmaceuticals in Scandinavia industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2013-17, and forecast to 2022). The profile also contains descriptions of the leading players including...

  • Pharmaceutical
  • F. Hoffmann-La Roche Ltd.
  • Hoffmann-La Roche Inc.
  • Novartis AG
  • Pfizer Inc.

TABLE ##: GERMANY PHARMACEUTICALS MARKET VALUE: $ BILLION, 2013-## MARKET DATA MARKET VALUE FIGURE ##: GERMANY PHARMACEUTICALS MARKET VALUE: $ BILLION, 2013-## MARKET SEGMENTATION GEOGRAPHY SEGMENTATION Germany accounts for ##. ##% of the European

  • Pharmaceutical
  • Bayer AG
  • Boehringer Ingelheim GmbH
  • F. Hoffmann-La Roche Ltd.
  • Hoffmann-La Roche Inc.
  • F. HOFFMANN-LA ROCHE
  • FIVE FORCES ANALYSIS

Infectious diseases and vaccines are one of the five major focus areas for Janssen Pharmaceuticals.

  • Antiviral
  • HIV Antiviral
  • Pharmaceutical
  • World
  • Hoffmann-La Roche Inc.
  • F. HOFFMANN-LA ROCHE LTD

The company operates through one business segment: human therapeutics.

  • Biotechnology
  • Pharmaceutical
  • World
  • Market Size
  • Hoffmann-La Roche Inc.
  • CANCER IMMUNOTHERAPIES DRUGS MARKET, GLOBAL, COMPANIES BY COMPOUND ANNUAL
  • 7.2.5 TABLE FOR CO-DEVELOPMENT DEALS WITH DISCLOSED DEAL VALUE

Kite Pharma Announces Positive Topline KTE-C## Data from ZUMA-## Business Wire.

  • Cancer Immunotherapy
  • Lung Cancer
  • Pharmaceutical
  • Therapy
  • Hoffmann-La Roche Inc.

Current Pharmaceutical Design; ##(##):##-##.

  • Artificial Intelligence
  • Healthcare
  • Information Technology
  • Pharmaceutical
  • Hoffmann-La Roche Inc.
  • F. HOFFMANN-LA ROCHE LTD

AstraZeneca has one business segment: biopharmaceuticals.

  • Biotechnology
  • Pharmaceutical
  • Therapy
  • AstraZeneca PLC
  • Hoffmann-La Roche Inc.
  • Vendor landscape

It is ranked as one of the top ## companies in the pharmaceuticals industry.

  • Pharmaceutical
  • United States
  • World
  • Forecast
  • Hoffmann-La Roche Inc.
  • SCOPE OF THE REPORT

In October 2015, Seattle Genetics collaborated with Takeda Pharmaceuticals to achieve target enrollment of Phase III ECHELON-## clinical trial to evaluate ADCETRIS.

  • Pharmaceutical
  • United States
  • Forecast
  • Market Size
  • Hoffmann-La Roche Inc.
  • Vendor landscape

KEY NEWS ENGERIX-B In July 2014, GSK and Isis pharmaceuticals signed a $##-million deal to develop new hepatitis B drugs.

  • Pharmaceutical
  • United States
  • World
  • Market Size
  • Hoffmann-La Roche Inc.
  • Vendor landscape
  • Market landscape

You can easily book an appointment with one online.

  • Hormones
  • Pharmaceutical
  • Hoffmann-La Roche Inc.
  • Novartis AG
  • Novo Nordisk Group
  • Vendor landscape
  • F. HOFFMANN-LA ROCHE

It blocks IL-## receptor signaling and prevents the binding of IL-##alpha and IL-## beta to the IL-## receptor.

  • Anti-Infective
  • Infectious Disease
  • Pharmaceutical
  • Gilead Sciences, Inc.
  • Hoffmann-La Roche Inc.
  • Global hepatitis therapeutics market
  • Vendor landscape

Genotype ## is the most common hepatitis C virus.

  • Hepatitis
  • Pharmaceutical
  • World
  • Market Size
  • Hoffmann-La Roche Inc.
  • Vendor landscape
  • Pipeline Portfolio

You can easily book an appointment with one online.

  • Asthma
  • Pharmaceutical
  • Respiratory Treatment
  • Market Size
  • Hoffmann-La Roche Inc.
  • KEY TAKEAWAY: COMPANIES WITH A STRONG INTEGRATION OF R&D AND MARKETING ARE LIKELY TO SUCCEED
  • Vendor landscape

February 2016: OSE Pharma initiates the Atalante ## Phase III trial designed to evaluate Tedopi for the potential treatment of advanced NSCLC.

  • Lung Cancer
  • Pharmaceutical
  • Therapy
  • AstraZeneca PLC
  • Hoffmann-La Roche Inc.
  • MARKET SHARE ANALYSIS 2015
  • Vendor landscape

Opdivo Binds to PD-## on T and NKT cells.

  • Pharmaceutical
  • United States
  • World
  • Market Size
  • Hoffmann-La Roche Inc.
  • F. HOFFMANN-LA ROCHE

Hoffmann-la Roche: Strength assessment Assessment Strength The company has a strong market presence and is one of the market leaders in the pharmaceutical industry.

  • Pharmaceutical
  • World
  • Forecast
  • Market Size
  • Hoffmann-La Roche Inc.
  • Vendor landscape
  • Market trends

ADC is one such approach.

  • Pharmaceutical
  • Therapy
  • Amgen Inc.
  • Hoffmann-La Roche Inc.
  • Merck & Co., Inc.
  • Vendor landscape
  • Scope of the report

You can easily book an appointment with one online.

  • Pharmaceutical
  • United States
  • Forecast
  • Market Size
  • Hoffmann-La Roche Inc.
  • Key vendor analysis
  • Opportunities

Roche is one of the major players in the market.

  • Pharmaceutical
  • Therapy
  • Vaccine
  • World
  • Hoffmann-La Roche Inc.
  • MARKET SHARE ANALYSIS 2015
  • Vendor landscape

Opdivo Binds to PD-## on T and NKT cells.

  • Pharmaceutical
  • United States
  • World
  • Market Size
  • Hoffmann-La Roche Inc.
  • Key vendor analysis
  • F. Hoffmann-La Roche

You can easily book an appointment with one online.

  • Pharmaceutical
  • Therapy
  • Vaccine
  • Amgen Inc.
  • Hoffmann-La Roche Inc.
  • Key takeaway: Companies with a strong integration of marketing and R&D are likely to
  • KEY VENDOR ANALYSIS

ADC is one such approach.

  • Cancer
  • Monoclonal Antibody
  • Pharmaceutical
  • Therapy
  • Hoffmann-La Roche Inc.
  • 21.2 F. HOFFMANN-LA ROCHE
  • 20.1 COMPETITIVE SCENARIO

It is ranked as one of the top ## companies in the Pharmaceutical industry.

  • Breast Cancer
  • Pharmaceutical
  • Therapy
  • Celgene Corporation
  • Hoffmann-La Roche Inc.
  • Key takeaway: Companies with a strong integration of marketing and R&D is likely to succeed
  • F. HOFFMANN-LA ROCHE

You can easily book an appointment with one online.

  • Cancer
  • Monoclonal Antibody
  • Pharmaceutical
  • Therapy
  • Hoffmann-La Roche Inc.
  • Vendor landscape
  • TOP-VENDOR OFFERINGS

You can easily book an appointment with one online.

  • Pharmaceutical
  • Respiratory Treatment
  • World
  • Market Size
  • Hoffmann-La Roche Inc.
  • ELI LILLY
  • MARKET ANALYSIS 2014

HOFFMANN-LA ROCHE ELI LILLY CELGENE ## Rank F.

  • Lung Cancer
  • Pharmaceutical
  • Therapy
  • AstraZeneca PLC
  • Hoffmann-La Roche Inc.
  • Vendor landscape

You can easily book an appointment with one online.

  • Pharmaceutical
  • United States
  • World
  • Market Size
  • Hoffmann-La Roche Inc.